Skip to main content

Table 1 Current UK vaccination against invasive meningococcal disease

From: The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol

Current UK Vaccination Against Invasive Meningococcal Disease
Vaccine (Serogroups) Year Introduced into schedule Age given
B 2015 8 weeks, 16 weeks, 1 year
C 1999 1 yeara
ACWY 2015 14 years, University students 19–25 years
  1. aPrior to 2016 meningococcal C vaccine was also administered at 12 weeks